CADM2 and central nervous system cancer: Cell adhesion molecule 2 (CADM2) is more expressed in subgroup 1, involved in maintenance of cell adhesion and tumor suppression, inhibiting glioma proliferation, migration, and invasion [76] (Fig. S6G).